Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dillon Bohinc"'
Autor:
Erica M. Sparkenbaugh, Michael W. Henderson, Megan Miller-Awe, Christina Abrams, Anton Ilich, Fatima Trebak, Nirupama Ramadas, Shantel Vital, Dillon Bohinc, Kara L. Bane, Chunsheng Chen, Margi Patel, Michael Wallisch, Thomas Renné, Andras Gruber, Brian Cooley, David Gailani, Malgorzata Kasztan, Gregory M. Vercellotti, John D. Belcher, Felicity E. Gavins, Evi X. Stavrou, Nigel S. Key, Rafal Pawlinski
Publikováno v:
Blood. 141:1871-1883
Data are available on request from the corresponding author, R. Pawlinski (rafal_pawlinski@med.unc.edu). The online version of this article contains a data supplement. The American Society of Hematology A hypercoagulable state, chronic inflammation,
Autor:
Lewis J. Hardy, Dillon Bohinc, Kara L. Bane, Samantha L. Heal, Emma Hethershaw, Majid Ali, Thomas Palmer-Dench, Richard Foster, Colin Longstaff, Thomas Renné, Evi X. Stavrou, Helen Philippou
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:814-827
Autor:
Michelle A. Cruz, Dillon Bohinc, Elizabeth A. Andraska, Jurgis Alvikas, Shruti Raghunathan, Nicole A. Masters, Nadine D. van Kleef, Kara L. Bane, Kathryn Hart, Kathryn Medrow, Michael Sun, Haitao Liu, Shannon Haldeman, Ankush Banerjee, Emma M. Lessieur, Kara Hageman, Agharnan Gandhi, Maria de la Fuente, Marvin T. Nieman, Timothy S. Kern, Coen Maas, Steven de Maat, Keith B. Neeves, Matthew D. Neal, Anirban Sen Gupta, Evi X. Stavrou
Publikováno v:
Nature nanotechnology, vol 17, iss 9
Nat Nanotechnol
Nat Nanotechnol
Targeted drug delivery to disease-associated activated neutrophils can provide novel therapeutic opportunities while avoiding systemic effects on immune functions. We created a nanomedicine platform that uniquely utilizes an α(1)-antitrypsin-derived
Autor:
Michelle A, Cruz, Dillon, Bohinc, Elizabeth A, Andraska, Jurgis, Alvikas, Shruti, Raghunathan, Nicole A, Masters, Nadine D, van Kleef, Kara L, Bane, Kathryn, Hart, Kathryn, Medrow, Michael, Sun, Haitao, Liu, Shannon, Haldeman, Ankush, Banerjee, Emma M, Lessieur, Kara, Hageman, Agharnan, Gandhi, Maria, de la Fuente, Marvin T, Nieman, Timothy S, Kern, Coen, Maas, Steven, de Maat, Keith B, Neeves, Matthew D, Neal, Anirban, Sen Gupta, Evi X, Stavrou
Publikováno v:
Nature nanotechnology. 17(9)
Targeted drug delivery to disease-associated activated neutrophils can provide novel therapeutic opportunities while avoiding systemic effects on immune functions. We created a nanomedicine platform that uniquely utilizes an α